¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"endothelial leukocyte adhesion molecule"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
À̰ÍÀ» ¿øÇϼ̽À´Ï±î?
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
¿µ¹® white blood cell(WBC), leukocyte ÇÑ±Û ¹éÇ÷±¸
¼³¸í   
  Ç÷¾×³»¿¡ °ñ¼ö±¸°è¼¼Æ÷¿Í ¸²ÇÁ°è¼¼Æ÷, ´ÜÇÙ±¸°è¼¼Æ÷¸¦ ¸ðµÎ ÅëÆ²¾î ¸»ÇÑ´Ù. ¹éÇ÷±¸ÀÇ Áõ°¡°¡ ÀÖÀ¸¸é ´ë°³ °¨¿°ÀÌ Àְųª, È¤Àº Å»¼öÇö»óÀÌ ÀÖÀ½À» ÀǹÌÇÑ´Ù. ¶ÇÇÑ Áö³ªÄ£ ¹éÇ÷±¸¼öÀÇ °¨¼Ò´Â ÀÎü³» ¸é¿ª±â´ÉÀÌ ¶³¾îÁ® ÀÖÀ½À» ÀǹÌÇϸç, ´Ù¸¥ Áúº´¿¡ ÀÇÇØ ³ªÅ¸³ª´Â ÀÌÂ÷ÀûÀΠÇö»óÀÌ ¾Æ´ÑÁö ²À Áø´ÜÀ» ¹Þ¾Æº¸¾Æ¾ß ÇÑ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • endothelial leukocyte adhesion molecule
    ³»ÇǹéÇ÷±¸ºÎÂøºÐÀÚ
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • endothelial adhesion molecule
    ³»ÇǺÎÂøºÐÀÚ
  • endothelial leukocyte
    ³»ÇǹéÇ÷±¸
  • adhesion molecule
    ºÎÂøºÐÀÚ
  • cell adhesion molecule
    ¼¼Æ÷ºÎÂøºÐÀÚ
  • intercellular adhesion molecule
    ¼¼Æ÷»çÀ̺ÎÂøºÐÀÚ, ¼¼Æ÷°£ºÎÂøºÐÀÚ
  • vascular cell adhesion molecule
    Ç÷°ü¼¼Æ÷ºÎÂøºÐÀÚ
  • leukocyte adhesion deficiency
    ¹éÇ÷±¸ºÎÂø°áÇÌ
  • endothelial bud
    ³»ÇǽÏ
  • endothelial cell
    ³»ÇǼ¼Æ÷
  • Fuchs endothelial dystrophy
    Ç«½º³»ÇǼ¼Æ÷ÀÌ»óÁõ
  • intravascular papillary endothelial hyperplasia
    Ç÷°ü³»À¯µÎ¸ð¾ç³»ÇǼ¼Æ÷Áõ½Ä
  • iridocorneal endothelial syndrome
    ȫä°¢¸·³»ÇÇÁõÈıº
  • papillary endothelial hyperplasia
    À¯µÎ¸ð¾ç³»ÇǼ¼Æ÷Áõ½Ä
  • vascular endothelial growth factor
    Ç÷°ü³»ÇǼºÀåÀÎÀÚ
  • adhesion
    1. À¯Âø 2. ºÎÂø, ºÙÀ½
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 8 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • intercellular adhesion molecule
    ¼¼Æ÷°£ºÎÂøºÐÀÚ
  • vascular endothelial growth factor
    Ç÷°ü³»ÇǼºÀåÀÎÀÚ
  • molecule
    ºÐÀÚ
  • adhesion
    ºÎÂø, À¯Âø, ºÙÀ½
  • platelet adhesion
    Ç÷¼ÒÆÇºÎÂø
  • leukocyte concentrate
    ¹éÇ÷±¸³óÃ๰
  • leukocyte
    ¹éÇ÷±¸
  • polymorphonuclear leukocyte
    ´ÙÇüÇÙ¹éÇ÷±¸
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • endothelial leukocyte adhesion molecule
    ³»ÇǼ¼Æ÷¹éÇ÷±¸ºÎÂøºÐÀÚ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • endothelial adhesion molecule
    ³»ÇǺÎÂøºÐÀÚ
  • endothelial leukocyte
    ³»ÇǹéÇ÷±¸
  • cell adhesion molecule
    ¼¼Æ÷ºÎÂøºÐÀÚ
  • intercellular adhesion molecule
    ¼¼Æ÷°£ºÎÂøºÐÀÚ
  • vascular cell adhesion molecule
    Ç÷°ü¼¼Æ÷À¯ÂøºÐÀÚ
  • leukocyte adhesion deficiency
    ¹éÇ÷±¸ºÎÂø°áÇÌÁõ
  • endothelial bud
    ³»ÇǽÏ
  • endothelial cell
    ³»ÇǼ¼Æ÷
  • vascular endothelial growth factor
    Ç÷°ü³»ÇǼºÀåÀÎÀÚ
  • intravascular papillary endothelial hyperplasia
    Ç÷°ü³»À¯µÎ¸ð¾ç³»ÇǼ¼Æ÷Áõ½Ä
  • papillary endothelial hyperplasia
    À¯µÎ¸ð¾ç³»ÇǼ¼Æ÷Áõ½Ä
  • adhesion
    ºÎÂø, À¯Âø, ºÙÀ½
  • adhesion deficiency disorder
    À¯Âø°áÇÌÀå¾Ö
  • conjunctival adhesion
    °á¸·À¯Âø
  • interthalamic adhesion
    ½Ã»ó»çÀ̺ÙÀ½
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • platelet endothelial cell adhesion molecule 1(pecam-1)
    Ç÷¼ÒÆÇ³»ÇǼ¼Æ÷ºÐÀÚ(úìá³÷ùÒ®ù«á¬øàÝÂí­)1
  • ICE syndrome=iridocorneal endothelial syndrome
    ȫä°¢¸·³»ÇÇÁõÈıº
  • fusiform endothelial cell
    ¹æÃß³»ÇǼ¼Æ÷
  • MHC molecule
    MHC ºÐÀÚ
  • activated molecule
    Ȱ¼ºÈ­ºÐÀÚ.
  • gram molecule
    ±×·¥ºÐÀÚ.
  • hybrid antibody molecule
    ÇÏÀ̺긮µåÇ×üºÐÀÚ
  • polymer molecule
    ÁßÇÕüºÐÀÚ(ñìùêô÷ÝÂí­).
  • Cell adhesion molecules
    ¼¼Æ÷À¯ÂøºÐÀÚ
  • Immunoglobulin adhesion receptors
    ¸é¿ª±Û·ÎºÒ¸° ºÎÂø(ݾó·)¼ö¿ëü
  • adhesion
    À¯Âø
  • adhesion
    À¯Âø, ºÎÂø, Á¢Âø.
  • adhesion
    À¯Âø
  • adhesion
    ºÎÂø
  • adhesion molecules
    ºÎÂø(ݾó·), Á¢ÂøºÐÀÚ(ïÈó·ÝÂí­)
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • endothelial leukocyte adhesion molecule
    ³»ÇǼ¼Æ÷¹éÇ÷±¸ À¯ÂøºÐÀÚ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • endothelial adhesion molecule
    ³»ÇǼººÎÂøºÐÀÚ
  • platelet endothelial cell adhesion molecule 1(pecam-1)
    Ç÷¼ÒÆÇ³»ÇǼ¼Æ÷ºÐÀÚ(úìá³÷ùÒ®ù«á¬øàÝÂí­)1
  • leukocyte adhesion molecule-1=LAM
    ¹éÇ÷±¸ ºÎÂø ºÐÀÚ-1
  • cell adhesion molecule
    ¼¼Æ÷ºÎÂøºÐÀÚ
  • intercellular adhesion molecule 1(icam-1)
    ¼¼Æ÷°£(á¬øàÊà) Á¢ÂøºÐÀÚ(ïÈó·ÝÂí­) 1 (ICAM-1)
  • intercellular adhesion molecule-1 (ICAM-1)
    ¼¼Æ÷°£ À¯ÂøºÐÀÚ-1
  • vascular cell adhesion molecule 1(vcam-1)
    ¸Æ°üÀÇ ¼¼Æ÷À¯ÂøºÐÀÚ1(VCAM-1)
  • vascular cell adhesion molecule
    Ç÷°ü ¼¼Æ÷ À¯Âø ºÐÀÚ
  • endothelial leukocyte
    ³»ÇǼº ¹éÇ÷±¸(?ËÑÌ´Ë´).
  • leukocyte adhesion deficiency
    ¹éÇ÷±¸ Á¢Âø °áÇÌ(¡­ ïÈó· ÌÀù¹)
  • leukocyte adhesion deficiency =LAD
    ¹éÇ÷±¸ ºÎÂø °áÇÌÁõ
  • atherosclerosis,endothelial injury
    ³»ÇǼջó(Ò®ù«áßß¿)
  • endothelial bud
    ³»ÇǽÏ
  • endothelial cell
    ³»ÇǼ¼Æ÷
  • endothelial cell
    ³»ÇǼ¼Æ÷(Ò®ù«á¬øà)
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Interthalamic adhesion
    ½Ã»ó»çÀ̺ÙÀ½
    [¿¾ ¿ë¾î] ½Ã»ó°£±³
  • Adhesion
    À¯Âø
    [¿¾ ¿ë¾î] À¯Âø
  • Endothelial cell
    ³»ÇǼ¼Æ÷
    [¿¾ ¿ë¾î] ³»ÇǼ¼Æ÷
  • Endothelial bud
    ³»ÇǽÏ
    [¿¾ ¿ë¾î] ³»ÇǾÆ
  • Nonfenestrated endothelial cell
    ¹Îâ³»ÇǼ¼Æ÷
    [¿¾ ¿ë¾î] ¹«Ã¢³»ÇǼ¼Æ÷
  • Fusiform endothelial cell
    ¹æÃß³»ÇǼ¼Æ÷
    [¿¾ ¿ë¾î] ¹æÃß»ó³»ÇǼ¼Æ÷
  • Fenestrated endothelial cell
    â³»ÇǼ¼Æ÷
    [¿¾ ¿ë¾î] À¯Ã¢³»ÇǼ¼Æ÷
  • Granular leukocyte
    °ú¸³¹éÇ÷±¸
    [¿¾ ¿ë¾î] °ú¸³¹éÇ÷±¸
  • Globule leukocyte
    µÕ±Ù°ú¸³¹é¼¼Æ÷
    [¿¾ ¿ë¾î] ±¸»ó¹éÇ÷±¸
  • Agranular leukocyte
    ¹«°ú¸³¹éÇ÷±¸
    [¿¾ ¿ë¾î] ¹«°ú¸³¹éÇ÷±¸
  • Acidophilic metamyelocyte [Juvenile acidophilic leukocyte]
    È£»ê¼º´Ê°ñ¼ö¼¼Æ÷ [¾î¸°È£»ê¼º¹éÇ÷±¸]
    [¿¾ ¿ë¾î] »êÈ£¼ºÈİñ¼ö¼¼Æ÷
  • Acidophilic leukocyte
    È£»ê¼º¹éÇ÷±¸
    [¿¾ ¿ë¾î] »êÈ£¼º¹éÇ÷±¸
  • Basophilic metaleukocyte [Juvenile basophilic leukocyte]
    È£¿°±â¼º´Ê°ñ¼ö¼¼Æ÷ [¾î¸°È£¿°±â¼º¹éÇ÷±¸]
    [¿¾ ¿ë¾î] ¿°±âÈ£¼ºÈİñ¼ö¼¼Æ÷
  • Basophilic leukocyte
    È£¿°±â¼º¹éÇ÷±¸
    [¿¾ ¿ë¾î] ¿°±âÈ£¼º¹éÇ÷±¸
  • Neutrophilic metamyelocyte [Juvenile neutrophilic leukocyte]
    È£Áß¼º´Ê°ñ¼ö¼¼Æ÷ [¾î¸°È£Áß¼º¹éÇ÷±¸]
    [¿¾ ¿ë¾î] Áß¼ºÈ£¼ºÈİñ¼ö¼¼Æ÷
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 13 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • cell adhesion molecule
    ¼¼Æ÷ºÎÂøºÐÀÚ(á¬øàÜõó·ÝÂí­)
  • endothelial cells
    ³»ÇǼ¼Æ÷ (Ò®ù«á¬øà)
  • leukocyte
    ¹éÇ÷±¸(ÛÜúìϹ)
  • leukocyte inhibitory factor
    ¹éÇ÷±¸ÀúÇØÀÎÀÚ(ÛÜúìϹîÁúªì×í­)
  • polymorphonuclear leukocyte
    ´ÙÇü¼º ¹éÇ÷±¸(ÒýúþàõÛÜúìϹ)
  • adhesion plaque
    Á¢Âø¹ÝÁ¡(ïÈó·ÚèïÇ)
  • adhesion protein
    ºÎÂø´Ü¹éÁú(ݾó·Ó±ÛÜòõ)
  • cell adhesion
    ¼¼Æ÷ºÎÂø(á¬øàÜõó·)
  • antenna molecule
    ¾ÈÅ׳ª ºÐÀÚ(ÝÂí­)
  • Cairns molecule
    Äɸ¥½º ºÐÀÚ(ÝÂí­)
  • informational molecule
    Á¤º¸ºÐÀÚ(ï×ÜÃÝÂí­)
  • light-harvesting molecule
    Áý±¤ºÐÀÚ(ó¢ÎÃÝÂí­)
  • molecule
    ºÐÀÚ(ÝÂí­)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 11 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • endothelial cyst
    ³»ÇǼº³¶
  • molecule
    ºÐÀÚ
  • adhesion
    À¯Âø,ºÎÂø, Á¢Âø
  • omental adhesion syndrome
    ´ë¸Á¸·À¯ÂøÁõÈıº
  • pericardiac adhesion
    ½É³¶À¯Âø
  • agranular leukocyte
    ¹«°ú¸³¹éÇ÷±¸
  • HLA[=human leukocyte antigen]
    HLAÇ׿ø, Àΰ£¹éÇ÷±¸Ç׿ø
  • leucocyte;leukocyte
    ¹éÇ÷±¸
  • leukocyte
    ¹éÇ÷±¸
  • polymorphonuclear leukocyte
    ´ÙÇüÇÙ¹éÇ÷±¸, ´ÙÇüÇÙ±¸
  • segmented leukocyte
    ºÐ¿±ÇÙ±¸
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
ELAM endothelial leukocyte adhesion molecule
CAM calf aortic microsome; cell adhesion molecule; cell-associating molecule; chorioallantoic membrane; ...
PECAM platelet-endothelial cell adhesion molecule
AMOG adhesion molecule on glia
ICAM intercellular adhesion molecule
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
ELAM Endothelial Leukocyte Adhesion Molecule
sVCAM-1 adhesion molecule 1 , vascular cell adhesion molecule 1
ALCAM Activated leukocyte cell adhesion molecule
ECAM endothelial cell adhesion molecule
ELAM-1 Endothelial leucocyte adhesion molecule-1
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • molecule
    ºÐÀÚ
    ´Üµ¶À¸·Î Á¸ÀçÇÒ ¼ö ÀÖ´Â ¹°ÁúÀÇ ÃÖ¼Ò·®. ¿øÀÚÀÇ ÁýÇÕü, ƯÈ÷ ƯÁ¤ÇÑ È­Çй°ÁúÀ» Çü¼ºÇÏ´Â 2°³ ¶Ç´Â ±× ÀÌ»óÀÇ ¿ø¼ÒÀÇ È­ÇÐÀû ¹èÇÕ. ºÐÀÚ¸¦ ±× ±¸¼º ¿ø¼Ò·Î ºÐÇØÇÏ¸é ±× ¼º»óÀÌ º¯ÇÑ´Ù. ºÐÀÚ³»ÀÇ ¿ø¼ÒÀÇ ¼ö³­ Á¾·ù´Â È­ÇÕ¹°¿¡ µû¶ó¼­ ´Ù¸£´Ù.
  • organic molecule
    À¯±â¹° ºÐÀÚ
  • photosensitive molecule
    ±¤ °¨ÀÛ¼º ºÐÀÚ
  • surface molecule
    Ç¥¸é¿¡ ÀÖ´Â ºÐÀÚ
  • unbranched molecule
    °¡Áö ¾ø´Â ºÐÀÚ
  • endothelial cell
    ³»ÇÇ ¼¼Æ÷
  • endothelial cyst
    ³»ÇǼº ³¶
  • endothelial myeloma
    ³»ÇÇ °ñ¼öÁ¾
    µ¿ÀǾî=Ewing's sarcoma.
  • iridocorneal-endothelial syndrome
    ȫä °¢¸· ³»ÇÇ ÁõÈıº
  • pyknotic endothelial cell
    ³óÃà ÇÙ ³»ÇÇ ¼¼Æ÷
  • vascular endothelial growth factor
    ¸Æ°ü ³»ÇǼ¼Æ÷ ¼ºÀå ÀÎÀÚ, Ç÷°ü ³»ÇǼ¼Æ÷ ¼ºÀå ÀÎÀÚ
  • adhesion
    À¯Âø, ºÎÂø, Á¢Âø
    1. Á¢ÃË¿¡ ÀÇÇØ ÀÎÁ¢ÇÑ µÎ ¸é »çÀÌÀÇ ºÐÀÚ°¡ ¼­·Î ²ø¾î´ç±â´Â °Í. ¿°Áõ ¹ÝÀÀ ÈÄ ¶Ç´Â ¿Ü»ó ȸº¹ÀÇ °á°ú·Î ÀÎÇÑ ÀÎÁ¢ ±¸Á¶¹°ÀÇ ºñÁ¤»óÀûÀÎ ¼¶À¯¼º °áÇÕÀÌ´Ù. 2. ±ÙÁ¢ ºÎÀ§¿¡ ³²¾Æ ÀÖ´Â ¼ºÁú·Î¼­ ¹°Áú¿¡ ´ëÇÑ ºÐÀÚÀÇ ¹°¸®ÀûÀÎ Àη ¶Ç´Â Á¢ÃË ¹°Ã¼ÀÇ Ç¥¸é°£¿¡ Á¸ÀçÇÏ´Â ºÐÀÚ Àη¿¡ ÀÇÇÑ´Ù. 3. ºñÁ¤»óÀûÀ¸·Î ÀϾ´Â, µÑ »çÀÌÀÇ ¾ÈÁ¤ÀûÀÎ °áÇÕ. 4. ºñÁ¤»óÀûÀ¸·Î ºÎÂøµÇ´Â ¼¶À¯ ¸ð¾çÀÇ ¶ì³ª ±¸Á¶¹°. 5. ±ÙÁ¢ ºÎÀ§¿¡ ³²¾Æ ÀÖ´Â ¼ºÁú·Î ¹°Áú¿¡ ´ëÇÑ ºÐÀÚÀÇ ¹°¸®ÀûÀÎ Àη ¶Ç´Â Á¢Ã˹°Ã¼ÀÇ Ç¥¸é°£¿¡ Á¸ÀçÇÏ´Â ºÐÀÚ°£ ÀηÂÀ¸·Î ¹ß»ý. 6. °¢°¢ÀÇ ºÎºÐÀÌ ¾ÈÁ¤µÇ°Ô °áÇÕÇÏ´Â °ÍÀ¸·Î ºñÁ¤»óÀûÀ¸·Î ¹ß»ýÇÒ ¼öµµ ÀÖ´Ù. 7. ºñÁ¤»óÀûÀ¸·Î À¯ÂøµÈ ¼¶À¯¼º ¹êµå ¶Ç´Â ±¸Á¶¹°.
  • adhesion of cement
    ½Ã¸àÆ® Á¢Âø
  • adhesion reaction
    À¯Âø ¹ÝÀÀ, ºÎÂø ¹ÝÀÀ
  • adhesion ulcer
    À¯Âø ±Ë¾ç, À¯Âø¼º ±Ë¾ç
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
endothelial-leukocyte adhesion molecule 115,000 Mw molecule on the surface of endothelial cells that is involved in blood leukocyte attachment to vessel walls as well as emigration from the vessels into the tissues.
(05 Mar 2000)
vascular cell adhesion molecule-1 Cytokine-induced cell adhesion molecule present on activated endothelial cells, tissue macrophages, dendritic cells, bone marrow fibroblasts, myoblasts, and myotubes. It is important for the recruitment of leukocytes to sites of inflammation.
(12 Dec 1998)
cell adhesion molecule <molecular biology> Although this could mean any molecule involved in cellular adhesive phenomena, it has acquired a more restricted sense, namely a molecule on the surface of animal tissue cells, antibodies (or Fab fragments) against that specifically inhibit some form of intercellular adhesion.
Examples are Liver Cell Adhesion Molecule and Neural Cell Adhesion Molecule, both named from tissues in which first detected, although their occurrence is not in fact restricted to these.
Acronym: CAM
(26 Nov 1998)
neural cell adhesion molecule See: NCAM.
(18 Nov 1997)
intercellular adhesion molecule See: ICAM.
(18 Nov 1997)
intercellular adhesion molecule-1 <chemical> A cell-surface ligand with a role in leukocyte adhesion and inflammation. Its production is induced by gamma-interferon and it is required for neutrophil migration into inflamed tissue.
Chemical name: Glycoprotein ICAM 1 (human clone pHRVr1 deblocked protein moiety reduced)
(12 Dec 1998)
endothelial leukocyte Old term for a monocyte, a type of leukocyte thought to be derived from reticuloendothelial tissue.
(05 Mar 2000)
receptors, leukocyte-adhesion Family of proteins associated with the capacity of leukocytes, including lymphocytes, monocytes, and neutrophils, to adhere to each other and to certain substrata, e.g., the c3bi component of complement. Members of this family are the lymphocyte function-associated antigen-1 (lfa-1), the macrophage-1 antigen (mac-1), and the antigen p150,95 or p150,95 leukocyte adhesion protein. They all share a common beta-subunit which is the CD18 antigen. All three of the above antigens are absent in inherited leukocyte-adhesion deficiency syndrome, which is characterised by recurrent bacterial infections, impaired pus formation, and wound healing as well as abnormalities in a wide spectrum of adherence-dependent functions of granulocytes, monocytes, and lymphoid cells.
(12 Dec 1998)
leukocyte adhesion deficiency An inherited disorder (autosomal recessive) in which there is a defective CD18 adherence complex that disturbs leukocyte chemotaxis. It is characterised by recurrent bacterial infections and impaired wound healing.
(05 Mar 2000)
leukocyte-adhesion deficiency syndrome <syndrome> Rare, autosomal recessive disorder caused by deficiency of the beta 2 integrin receptors (receptors, leukocyte-adhesion) comprising the CD11/CD18 family of glycoproteins. The syndrome is characterised by abnormal adhesion-dependent functions, especially defective tissue emigration of neutrophils, leading to recurrent infection.
(12 Dec 1998)
repellant guiding molecule <cell biology> Specific molecules that inhibit the activity of growth cones and are thought to be important in establishing axon pathways during nervous system development.
See: growth cone collapse.
(18 Nov 1997)
gram-molecule <unit> The amount of a substance with a mass in grams equal to its molecular weight; e.g., a gram-molecule of hydrogen weighs 2.016 g, that of water 18.015 g.
(05 Mar 2000)
chimeric molecule A molecule (usually a biopolymer) containing sequences derived from two different genes; specifically, from two different species.
Compare: chimera.
(05 Mar 2000)
molecule <chemistry> The result of two or more atoms combining by chemical bonding.
(09 Oct 1997)
hybrid molecule <molecular biology> A double-stranded nucleic acid molecule which was artificially created from two different single-stranded nucleic acid molecules from different sources, for the purpose of comparing their nucleotide sequences.
(09 Oct 1997)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 8 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • adhesion
    ºÎÂø
  • adhesion
    ÁýÂø;Á¡Âø;À¯ÀÛ
  • leukocyte
    ¹éÇ÷±¸
  • molecule
    ºÐÀÚ
  • leukocyte
    ¹éÇ÷±¸
  • molecule
    ºÐÀÚ
  • nuclear molecule
    (¹°)¿øÀÚÇÙ ºÐÀÚ
  • polymorphonuclear leukocyte
    ´ÙÇ÷ÇÙ ¹éÇ÷±¸
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á